Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity

Research Communications in Molecular Pathology and Pharmacology

Volumn 93, Issue 2, 1996, Pages 163-170

  DiSilvestro, Robert A ^a   Liu, Jie ^b   Klaassen, Curtis D ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; GENE EXPRESSION; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURVIVAL; TRANSGENIC MOUSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; GLUTATHIONE; HEART; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0029814835     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bauman JW, McKim JMJ, Liu J and Klaassen CD (1992) Induction of metallothionein by diethyl maleate. Toxi. Appli. Pharm. 114, 188-196.
2. Cousins RJ (1985) Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 65, 238-309.
3. DiSilvestro RA and Joseph E (1995) An acute phase response does not elevate rat heart metallothionein levels, nor inhibit adriamycin toxicity. Res Commun Molec Pathol Pharmacol 88, 107-114.
4. Eaton DL and Toal BF (1982) Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxi. Appli. Pharm. 66, 134-142.
5. Hidalgo J, Garvey JS and Armario A (1990) On the metallothionein, glutathione and cysteine relationship in rat liver. J. Pharmacol. Exp. Ther. 255, 554-564.
6. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241, 1813-1815.
7. Kondo Y, Woo ES, Michalska KH, Choo A and Lazo JS (1995) Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 55, 2021-2023.
8. Liu J and Klaassen CD (1996) Absorption and distribution of cadmium in metallothionein-1 transgenic mice. Fundam Appl Toxicol 29, 294-300.
9. Naganuma A, Satoh M and Imura N (1987) Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 47, 983-987.
10. Naganuma A, Satoh M and Imura N (1988) Specific reduction of toxic side effects of adriamycin by induction of metallothionein in Mice. Jpn J Cancer Res 79, 406-411.
11. Olson RD, MacDonald JS, vanBoxtel CJ, Boerth RC, Harbison RB, Slonim AE, Freeman RW and Oates JA (1980) Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. J. Pharmacol. Exp. Ther. 215, 450-545.
12. Onosaka, S and Cherian MG (1981) The induced synthesis of metallothionein in various tissues of rats in response to metals. I. Effect of repeated injection of cadmium salts. Toxicol. 22, 91-101.
13. Sato M, Sasaki M and Hojo H (1992) Tissue specific induction of metallotheinein synthesis by tumor necrosis factor-α. Res. Commun. Chem. Pathol. Pharmacol. 75, 159-172.
14. Sharma G, Nath R and Gill KD (1992) Effect of ethanol on the distribution of cadmium between the cadmium metallothionein- and non-metallothionein-bound cadmium pools in cadmium-exposed rats. Toxicology 72, 151-163.
15. Villani F, Galimberti M, Monti E, Piccini F, Lanza E, Rozza A, Favalli L, Poggi P and Zunino F (1990) Effect of glutathione and n-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicin. Free Rad. Res. Comm. 11, 145-151.
16. Yang FL and DiSilvestro RA (1996) Effects of dietary zinc restriction on bismuth induction of rat kidney metallothionein. J. Nutr. Biochem. 7, 196-199.